Koninklijke Philips - AGM 09 May 2019
In general, Koninklijke Philips ("Philips") is in compliance with the Dutch regulations relating to the organisation and procedures of the Annual General Meeting.
Under ITEM 4a, it is proposed to re-appoint Mr. David Pyott as Member of the supervisory board. Although he is considered independent, ECGS has concerns over his aggregate time commitments. Mr. Pyott is serving as Chairman of the board of directors of Bioniz Therapeutics LLC (substantial non-listed company) and non-executive director of Avery Dennison Inc, Koninklijke Philips N.V, Alnylam Pharmaceuticals Inc and Biomarin Pharmaceutical Inc. (all listed), which exceed ECGS' guidelines. In view of concerns over aggregate time commitments, ECGS recommends to vote OPPOSE.
Under ITEM 7, the executive board, subject to approval of the supervisory board, seeks authorisation to repurchase own shares. In aggregate, the authority requested is limited to 20% of the Company's share capital and thereby exceeds ECGS' guidelines. Accordingly, ECGS recommends to vote OPPOSE.
There are no further peculiarities.
Koninklijke Philips Electronics is active in the markets of healthcare, consumer lifestyle and lighting. Co.'s activities can be divided into three segments: Healthcare (Co. provides Imaging Systems, Patient Care and Clinical Informatics, Home Healthcare Solutions and Customer Services), Consumer Lifestyle (Co.'s products are divided into the following: Health and Wellness; Domestic Appliances; and Lifestyle Entertainment), Lighting (Co. provides lighting solutions for homes, shops, offices, schools, hotels, factories and hospitals; Co. also offers solutions for roads (street lighting and car lights) and for public spaces, residential areas and sports arenas).
Founded in 1995, Proxinvest is an independent proxy firm supporting the engagement and proxy analysis processes of investors. Proxinvest mission is to analyse corporate governance practices and resolutions proposed at general meetings of listed firms.
Proxinvest main services are :
- Proxy reports
- Definition and monitoring of client customized voting guidelines
- Corporate Governance Data and Rating
- Thematic research
- Engagement support
Proxinvest has been a pioneer and champion of good corporate governance and has grown into a recognised expert in the field.
Proxinvest is independently-owned and only works for investors : Proxinvest does not provide consulting services to the companies it covers, mitigating related risks to its clients and ensuring the independence of our analysis. As a result Proxinvest is able to take a robust, independent, engaged and unconflicted view of the companies in which our clients invest.
As Managing Partner of Expert Corprate Governance Service Ltd (ECGS), Proxinvest has built a large network of corporate governance experts to support clients in corporate governance analysis worldwide.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.